Trial Information
Prospective Study of Predictive Value of Dynamic Contrast Enhancement Magnetic Resonance Imaging With Gadolinium on the Response of a Cerebral Tumor to a Treatment With Gamma Knife
Inclusion Criteria:
- Patient with intracerebral lesion benign or malignant wich are not concerned by the
exclusion criteria
Exclusion Criteria:
- Pancranial radiotherapy
- Residual postop lesion
- Gliomas
- Patients < 18 years old
- Anterior allergic reaction to gadolinium
- Claustrophobia.
Type of Study:
Observational
Study Design:
Observational Model: Defined Population, Primary Purpose: Screening, Time Perspective: Longitudinal, Time Perspective: Prospective
Principal Investigator
Jean Chenard, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
University of Sherbrooke
Authority:
Canada: Health Canada
Study ID:
05-063
NCT ID:
NCT00156585
Start Date:
August 2005
Completion Date:
June 2006
Related Keywords:
- Cerebral Metastases
- cerebral metastases
- dynamic contrast enhanced magnetic resonance imaging
- DCE-MRI
- gamma knife
- Neoplasm Metastasis